Search by PDB author

The crystal structure of human abl1 kinase domain in complex with ABL1-A11
Descriptor:	5-[5-(dimethylcarbamoyl)pyridin-3-yl]-3-(5-fluorosulfonyloxy-2-methoxy-phenyl)-1H-pyrrolo[2,3-b]pyridine, Tyrosine-protein kinase ABL1
Authors:	Zhu, C, Zhang, Z.M.
Deposit date:	2021-12-06
Release date:	2022-04-27
Last modified:	2023-11-29
Method:	X-RAY DIFFRACTION (2.0000093 Å)
Cite:	Cell-Active, Reversible, and Irreversible Covalent Inhibitors That Selectively Target the Catalytic Lysine of BCR-ABL Kinase. Angew.Chem.Int.Ed.Engl., 61, 2022

Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors
Descriptor:	Tyrosine-protein kinase ABL1, [4-[5-[5-(dimethylcarbamoyl)pyridin-3-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-methyl-phenyl]boronic acid
Authors:	Anantharajan, J, Baburajendran, N.
Deposit date:	2020-06-16
Release date:	2021-06-09
Last modified:	2023-11-29
Method:	X-RAY DIFFRACTION (2.723 Å)
Cite:	*Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors.** Angew.Chem.Int.Ed.Engl., 60, 2021

Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors
Descriptor:	Tyrosine-protein kinase ABL1, [4-[5-[5-(dimethylcarbamoyl)pyridin-3-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-methanoyl-5-methoxy-phenyl]boronic acid
Authors:	Anantharajan, J, Baburajendran, N.
Deposit date:	2021-01-04
Release date:	2021-06-09
Last modified:	2023-11-29
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	*Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors.** Angew.Chem.Int.Ed.Engl., 60, 2021

Crystal structure of LmNADK1 from Listeria monocytogenes
Descriptor:	GLYCEROL, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, Probable inorganic polyphosphate/ATP-NAD kinase 1
Authors:	Labesse, G.
Deposit date:	2006-08-16
Release date:	2007-08-07
Last modified:	2024-02-21
Method:	X-RAY DIFFRACTION (2.1 Å)
Cite:	NAD kinases use substrate-assisted catalysis for specific recognition of NAD. J.Biol.Chem., 282, 2007